Cardinal Health Stock Forecast, Price & News

10 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cardinal Health in the last year. There are currently 4 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Cardinal Health stock.
View analyst ratings for Cardinal Health or view top-rated stocks.

Wall Street analysts have given Cardinal Health a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardinal Health wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Cardinal Health saw a decline in short interest during the month of March. As of March 15th, there was short interest totaling 4,240,000 shares, a decline of 21.3% from the February 28th total of 5,390,000 shares. Based on an average trading volume of 1,940,000 shares, the short-interest ratio is presently 2.2 days. Currently, 1.5% of the shares of the stock are short sold.
View Cardinal Health's Short Interest.

Cardinal Health is scheduled to release its next quarterly earnings announcement on Thursday, May 6th 2021.
View our earnings forecast for Cardinal Health.

Cardinal Health will be holding an earnings conference call on Thursday, May 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Cardinal Health, Inc. (NYSE:CAH) issued its quarterly earnings results on Thursday, February, 4th. The company reported $1.74 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.44 by $0.30. The business had revenue of $41.54 billion for the quarter, compared to the consensus estimate of $41.44 billion. Cardinal Health had a trailing twelve-month return on equity of 123.28% and a net margin of 0.63%. The company's revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the company posted $1.52 earnings per share.
View Cardinal Health's earnings history.

Cardinal Health's stock was trading at $48.65 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, CAH shares have increased by 25.5% and is now trading at $61.05.
View which stocks have been most impacted by COVID-19.

Cardinal Health declared a quarterly dividend on Monday, February 8th. Stockholders of record on Thursday, April 1st will be given a dividend of $0.4859 per share on Thursday, April 15th. This represents a $1.94 annualized dividend and a dividend yield of 3.18%. The ex-dividend date is Wednesday, March 31st.
View Cardinal Health's dividend history.

Cardinal Health pays an annual dividend of $1.94 per share and currently has a dividend yield of 3.17%. Cardinal Health has been increasing its dividend for 34 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio of Cardinal Health is 35.60%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 31.65% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.
View Cardinal Health's dividend history.

Cardinal Health updated its FY21 earnings guidance on Friday, February, 5th. The company provided earnings per share (EPS) guidance of $5.85-6.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $5.25.

10 brokerages have issued 1 year price targets for Cardinal Health's stock. Their forecasts range from $53.00 to $70.00. On average, they expect Cardinal Health's share price to reach $61.44 in the next year. This suggests a possible upside of 0.6% from the stock's current price.
View analysts' price targets for Cardinal Health or view top-rated stocks among Wall Street analysts.

357 employees have rated Cardinal Health CEO Mike Kaufmann on Glassdoor.com. Mike Kaufmann has an approval rating of 85% among Cardinal Health's employees.

Some companies that are related to Cardinal Health include McKesson (MCK), AmerisourceBergen (ABC), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI).
View all of CAH's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cardinal Health investors own include AbbVie (ABBV), AT&T (T), Johnson & Johnson (JNJ), CVS Health (CVS), Exxon Mobil (XOM), Pfizer (PFE), Chevron (CVX), Intel (INTC), Cisco Systems (CSCO) and PepsiCo (PEP).

Cardinal Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CAH."

Cardinal Health's stock is owned by a number of institutional and retail investors. Top institutional shareholders include Miller Howard Investments Inc. NY (0.37%), Wedge Capital Management L L P NC (0.19%), International Assets Investment Management LLC (0.14%), Liberty One Investment Management LLC (0.10%), Pacer Advisors Inc. (0.04%) and Kwmg LLC (0.04%).
View institutional ownership trends for Cardinal Health.

CAH stock was sold by a variety of institutional investors in the last quarter, including Cypress Capital Group, Retirement Systems of Alabama, NEXT Financial Group Inc, Oregon Public Employees Retirement Fund, V Wealth Advisors LLC, Thomasville National Bank, Hohimer Wealth Management LLC, and Livingston Group Asset Management CO operating as Southport Capital Management.
View insider buying and selling activity for Cardinal Health or view top insider-selling stocks.

CAH stock was bought by a variety of institutional investors in the last quarter, including International Assets Investment Management LLC, Clarus Group Inc., Hennessy Advisors Inc., Monument Capital Management, Pacer Advisors Inc., Wedge Capital Management L L P NC, TrimTabs Asset Management LLC, and Everence Capital Management Inc..
View insider buying and selling activity for Cardinal Health or or view top insider-buying stocks.

Shares of CAH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of CAH stock can currently be purchased for approximately $61.05.

Cardinal Health has a market capitalization of $17.93 billion and generates $152.92 billion in revenue each year. The company earns $-3,696,000,000.00 in net income (profit) each year or $5.45 on an earnings per share basis.

Cardinal Health employs 48,000 workers across the globe.

The following companies are subsidiares of Cardinal Health: A+ Secure Packaging LLC, Access Closure, Access Closure Inc., Aero-Med Ltd., Alaris Medical Systems, Allegiance Corporation, Allegiance Healthcare, AssuraMed, AssuraMed Inc., Automatic Liquid Packaging, Bergen Brunswig Corp, Bindley Western Industries, Boron LePore & Associates, Borschow Hospital & Medical Supplies, Cardinal Health 100 Inc., Cardinal Health 104 LP, Cardinal Health 105 Inc., Cardinal Health 107 LLC, Cardinal Health 108 LLC, Cardinal Health 110 LLC, Cardinal Health 112 LLC, Cardinal Health 113 LLC, Cardinal Health 114 Inc., Cardinal Health 115 LLC, Cardinal Health 116 LLC, Cardinal Health 118 LLC, Cardinal Health 119 LLC, Cardinal Health 121 LLC, Cardinal Health 122 LLC, Cardinal Health 123 LLC, Cardinal Health 124 LLC, Cardinal Health 126 LLC, Cardinal Health 127 Inc., Cardinal Health 2 LLC, Cardinal Health 200 LLC, Cardinal Health 201 Inc., Cardinal Health 222 (Thailand) Ltd., Cardinal Health 247 Inc., Cardinal Health 249 LLC, Cardinal Health 3 LLC, Cardinal Health 414 LLC, Cardinal Health 5 LLC, Cardinal Health 6 Inc., Cardinal Health 7 LLC, Cardinal Health Australia 503 Pty. Ltd., Cardinal Health Austria 504 GmbH, Cardinal Health Belgium 505 BVBA, Cardinal Health Canada Holdings Cooperative U.A., Cardinal Health Canada Inc., Cardinal Health Chile Limitada, Cardinal Health Colombia S.A.S., Cardinal Health D.R. 203 II Ltd., Cardinal Health Denmark ApS, Cardinal Health Finland Oy, Cardinal Health Foundation, Cardinal Health France 506 SAS, Cardinal Health Funding LLC, Cardinal Health Germany 507 GmbH, Cardinal Health Germany Manufacturing GmbH, Cardinal Health IPS LLC, Cardinal Health International Philippines Inc., Cardinal Health Ireland 419 Designated Activity Company, Cardinal Health Ireland 508 Limited, Cardinal Health Ireland Unlimited Company, Cardinal Health Italy 509 Srl, Cardinal Health Japan G.K., Cardinal Health Korea Limited, Cardinal Health Malaysia 211 Sdn. Bhd., Cardinal Health Malta 212 Limited, Cardinal Health Managed Care Services LLC, Cardinal Health Medical Equipment Consulting (Shanghai) Co. Ltd., Cardinal Health Medical Products India Private Limited, Cardinal Health Mexico 244 S. de R.L. de C.V., Cardinal Health Mexico 514 S. de R.L. de C.V., Cardinal Health Middle East FZ-LLC, Cardinal Health Netherlands 502 B.V., Cardinal Health Norway AS, Cardinal Health P.R. 120 Inc., Cardinal Health P.R. 218 Inc., Cardinal Health P.R. 220 LLC, Cardinal Health Pharmaceutical Contracting LLC, Cardinal Health Pharmacy Services LLC, Cardinal Health Poland Spółlka z ograniczonąa odpowiedzialnośsciąa, Cardinal Health Portugal 513 Unipessoal Lda., Cardinal Health Singapore 225 Pte. Ltd., Cardinal Health Spain 511 S.L., Cardinal Health Specialty Pharmacy LLC, Cardinal Health Sweden 512 A.B., Cardinal Health Switzerland 515 GmbH, Cardinal Health Systems Inc., Cardinal Health Technologies LLC, Cardinal Health Technologies Switzerland GmbH, Cardinal Health U.K. 432 Limited, Cardinal Health do Brasil Ltd., CareFusion, Cirpro de Delicias S.A. de C.V., Convertors de Mexico S.A. de C.V., Cordis, Cordis (Shanghai) Medical Devices Co. Ltd., Cordis Cashel Company Unlimited, Cordis Corporation, Cornerstone Partners G.P.O. L.P., Covidien Manufacturing Solutions S.A., Curaspan Health Group Inc., Denver Biomedical, Dik Drug, EPIC Insurance Company, Emerge Medical, Enturia, Especialidades Medicas Kenmex S.A. de C.V., Futuremed Health Care Products, Gala Biotech, Geodax Technology, Griffin Capital LLC, HLS Freight Services, Healthcare Solutions Holding, Innovative Therapies Inc., Instant Diagnostic Systems Inc., KPR Australia Pty. Ltd., KPR Italia S.r.l., KPR Switzerland Sales Gmbh, KPR U.S. LLC, Kendall Patient Recovery BVBA, Kendall-Gammatron Limited, Kinray, Leader Drugstores Inc., Limited Liability Company "Cardinal Health Russia", Ludlow Technical Products Canada Ltd., MCD, Magellan Laboratories, Marin Apothecaries, MedMined, Medicine Shoppe International Inc., Mediquip Sdn. Bhd., Medtronic - Patient Monitoring & Recovery, Mirixa Corporation, NaviHealth, Nippon Covidien Ltd., One Cloverleaf LLC, Outcomes Incorporated, Owen Healthcare, PCI Pharma Services, ParMed Pharmaceuticals, Pinnacle Intellectual Property Services Inc., Pinnacle Intellectual Property Services-International Inc., Post-Acute Care Center for Research LLC, Pyxis Corporation, Quiroproductos de Cuauhtemoc S. de R.L. de C.V., R Cubed Inc., R.P. Scherer Corporation, RGH Enterprises Inc., RainTree GPO LLC, RainTree Oncology Services, Renal Purchasing Group LLC, Rxealtime Inc., Sonexus Health LLC, Syncor International, TelePharm, TelePharm LLC, The Harvard Drug Group, The Harvard Drug Group L.L.C., Tradex International Inc., Viasys Healthcare, WaveMark Inc., Zuellig Pharma China, mscripts, mscripts LLC, and mscripts Systems India Private Limited.

Cardinal Health was founded in 1971.

The official website for Cardinal Health is www.cardinalhealth.com.

Cardinal Health is headquartered at 7000 CARDINAL PLACE, DUBLIN OH, 43017.

Cardinal Health's mailing address is 7000 CARDINAL PLACE, DUBLIN OH, 43017. The company can be reached via phone at 614-757-5000 or via email at [email protected]